MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • MassDevice Today
    • Cardiovascular
    • Clinical Trials
    • Legal News
    • Orthopedics
    • Regulatory/Compliance
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • More MedTech
    • Cosmetic/Aesthetic
    • Diabetes
    • Dialysis
    • Distribution
    • Imaging
    • Otolaryngology Ear, Nose & Throat
    • Pharma
    • Respiratory
    • Wound Care
  • Blog
  • DeviceTalks Podcasts
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • Videos
    • White Papers
  • DeviceTalks
Home » Geron’s exit from stem cell business means opportunity for InVivo, others

Geron’s exit from stem cell business means opportunity for InVivo, others

November 16, 2011 By MassDevice staff Leave a Comment

Share
MassDevice.com Wall Street Beat

New of Geron Corp.’s (NSDQ:GERN) plan to get out of the stem cells game could be a boon for other regenerative medicine firms, including InVivo Therapeutics (OTC:NVIV), Aastrom Biosciences (NSDQ:ASTM), StemCells (NSDQ:STEM) and Pluristem (NSDQ:PSTI).

Geron said Nov. 14 that it will ditch its embryonic stem cell research projects, citing "capital scarcity" and the cost of R&D as partial reasons for the move. The company will focus on cancer drugs going forward, it said.

That leaves a big opening for other firms that play in the space, according to a Seeking Alpha blogger.

Sign up to get our free newsletters delivered right to your inbox

"In fact, it bodes particularly well for InVivo Therapeutics," according to "Timeless Wealth," which bills itself as "a leading publisher of investment-opinion content supported by research."

"Geron’s GRNOPC1, a Human Embryonic Stem Cell (hESC) therapy, was in Phase I trials for the same indication – before Geron pulled the plug on the program," according to a post on the investment website. "Investors who sought exposure in stem cell research allocated capital and invested in Geron Corporation. And just as their clinical focus has shifted, so will investors’ dollars. Aastrom Biosciences, StemCells, and Pluristem are a few regenerative-medicine firms that could be the beneficiaries of a shift in assets. InVivo Therapeutics, similarly, is the only pure-play [spinal cord injury] company, and non-coincidentally, one that recently signed on Dr. Edward Wirth, who led the world’s first human embryonic stem cell clinical trial as medical director for regenerative medicine – at Geron."

Steris flags on slow FDA clearance for System 1E component
Sluggish sales of Steris Corp.’s (NYSE:STE) flagship sterilization device, the System 1E, are partly due to the FDA being slow to clear a crucial component of the device.

The Mentor, Ohio-based company’s product is a liquid chemical sterilization system for heat-sensitive medical instruments. The component in question is a biological indicator designed to signal that all living organisms have been killed by the device. And although it’s not necessary to run the device, it’s a feature desired by Steris customers and its lack of availability is holding back sales. Read more

Intuitive Surgical hits new 52-week high
Shares of Intuitive Surgical Inc. (NSDQ:ISRG) hit a new 52-week high yesterday, cresting at $449.06 before falling back to close at $448.77 – up 1.9 percent on a day when the S&P 500 gained only half a percent.

ISRG shares were trading at $445.30 as of about 11:20 this morning, up 0.8 percent.

Tengion to lay off half its staff
Tengion Inc. (NSDQ:TNGN) plans to lay off half of its employees as it looks to conserve cash and focus on R&D ahead of milestones it hopes to reach next year.

The regenerative medicine firm said it plans to lay off 30 workers, including chief medical officer Dr, Sunita Sheth and chief commercial officer Mark Stejbach. Read more

Imaging Diagnostic, Invo Bioscience, ThermoGenesis hit 52-week lows
Imaging Diagnostic Systems (OTC:IMDS), Invo Bioscience (OTC:IVOB) and ThermoGenesis (NSDQ:KOOL) each hit a 52-week low recently.

IMDS shares slipped to 0 cents yesterday in heavy trading. The stock was trading at 0.005 cents today as of about 12:30 p.m. IVOB shares hit 1 cent yesterday and KOOL shares hit 96 cents on their way to a $1 close.

Analysts’ ups and downs

  • Boston Scientific (NYSE:BSX): Leerink Swann lowers 2012 earnings prediction from 48 cents to 38 cents.
  • Amgen (NSDQ:AMGN): downgraded at Piper from Overweight to Neutral. $65 price target. Maturing brands are facing increased competition.
  • Steris (NYSE:STE): WJB Capital downgrades from “buy” to “hold.”
  • Cooper Cos. (NYSE:COO): BMO downgrades from "outperform" to "market perform," sets $64 price target.

Filed Under: News Well, Regenerative Medicine, Wall Street Beat Tagged With: Aastrom Biosciences Inc, Amgen, Boston Scientific, Geron Corp., Imaging Diagnostic Systems, Intuitive Surgical, InVivo Therapeutics, INVO Bioscience, Pluristem, StemCells Inc., Steris Corp., Tengion Inc., The Cooper Cos., ThermoGenesis Corp.

In case you missed it

  • Biotronik wins FDA nod for Orsiro DES
  • Nevro shares down on Q4, 2018 miss
  • Axonics wins expanded MRI-safe CE Mark approval for r-SNM system
  • Stimwave calls Nevro patent suit ‘baseless, unfounded’
  • FDA releases brain-computer interface draft guidance
  • Ocular Therapeutix inks $38m debt financing deal
  • Sen. Warner enlists healthcare industry help on cybersecurity
  • Medtech outsourcer innovations you need to know
  • Second Sight Medical closes $35m rights offering
  • Swiss heart valve dev Novostia raises $7m
  • Dexcom beats The Street with Q4, FY18 results
  • ViewRay wins FDA nod for MRIdian system soft tissue visualization capabilities
  • Boston Scientific prices $4.3B senior notes offering
  • Abbott touts real-world data for FreeStyle Libre glucose monitor
  • Mylan launches generic sublingual film for opioid dependence
  • Propeller Health study suggests 84% of asthma inhaler use performed incorrectly
  • LivaNova wins Japanese reimbursement for Perceval aortic valve

RSS From Medical Design & Outsourcing

  • High Precision Metrology Applications
    Cellular therapies and bio-fabrications are on the verge of revolutionizing how patients are treated for some of the most serious illnesses. These regenerative approaches are giving hope to both patients and their doctors for cures where today only symptomatic treatments are available. Precision automation in the laboratory is playing a key role in allowing these… […]
  • GW Plastics expands Ireland operations
    GW Plastics (Bethel, Vt.) recently announced that it is expanding its operations at its advanced manufacturing facility in Sligo, Ireland. The company plans to invest €6 million to grow its product development, precision tooling, thermoplastic and silicone injection molding and contract assembly capabilities. It also plans to expand molding operations to a scalable 28,000 sq.… […]
  • Medtech outsourcer innovations you need to know
    The medical device industry is seeing all kinds of innovations, but people often overlook the myriad medtech outsourcer technologies making innovation possible. From tiny sensors, magnets and cameras to materials and adhesives that get the job done, contract manufacturers and other suppliers are supporting the medical device industry in myriad ways. They’re enabling everything from… […]
  • Sen. Warner enlists healthcare industry help on cybersecurity
    U.S. Senator Mark Warner (D-Va.) wants healthcare organizations’ help to improve cybersecurity. Warner — a member of the Senate Finance Committee and chair of the Senate cybersecurity caucus — sent a letter to a number of healthcare organizations yesterday, pointing to the apparent gaps in oversight and expressing concern about the impact of cyberattacks on… […]
  • How adhesives are key to unlocking wearable medical device innovation
    It turns out that adhesives are a critical component to the success of wearables. Adhesives provide solutions to design challenges and help protect users’ skin from harm. Tony Kaufman and Del R. Lawson, 3M The healthcare landscape is constantly changing, with providers continuing to focus on delivering patient-centric care. Patients are increasingly able to access… […]
  • Medbio acquires AIM Plastics
    Medbio (Grand Rapids, Mich.) announced that it has acquired Detroit-based component manufacturer AIM Plastics. The financial details of the deal were not disclosed. AIM Plastics specializes in prototype-to-production molds and complex injection molding. It offers full-service injection molding and in-house tooling capabilities for therapeutic applications in the healthcare industry. “AIM is a truly transformative add-on… […]
  • How to design home healthcare devices that people will use
    Meeting consumer demands for home healthcare technology requires a keen knowledge of user behavior. Here are four ways companies are approaching the market. Scott Thielman, Product Creation Studio The global smart home healthcare market is exploding as more medical devices are designed for use wherever the patient is, including at home. A report by Research and… […]
  • Axonics Modulation touts results of sacral neuromodulation study
    Axonics Modulation Technologies (NSDQ:AXNX) announced positive top-line results from a pivotal study of its novel implantable sacral neuromodulation (SNM) devices for the treatment of urinary and bowel dysfunction. The clinical study demonstrated that patients implanted with the Axonics r-SNM system experienced clinically meaningful and statistically significant improvements in urinary urgency incontinence (UUI) symptoms and quality of… […]
  • Okay Industries appoints new marketing manager
    Okay Industries (New Britain, Conn.) announced that it has appointed Angela Dillon as its new marketing manager. As marketing manager, Dillon willed strategic initiative that will promote the Okay brand, support business development and manage both internal and external communications for talent recruitment and retention. “I am excited to announce this new role for Angela,”… […]
  • SIG Medical wins FDA clearance for rib fracture device
    SIG Medical (Hershey, Penn.) has received FDA 510(k) clearance for its enhanced AdvantageRib System, the K183317. The system is the third rib fracture system from SIG Medical that has received 510(k) clearance recently and is being commercialized. The most recent 510(k) includes new implants that treat patients, as well as the entire spectrum of bone… […]
  • Starr Surgical signs strategic cooperation agreement with Smile Eyes
    Starr Surgical (Monrovia, Calif.) recently announced that it has signed a strategic cooperation agreement with the Smile Eyes group in Germany and Austria. The Smile Eyes group is an alliance of more than 80 eye experts in 13 vision correction eye centers in Germany and Austria. Through the agreement, EVO Visian ICL lenses will be… […]

Leave a Reply Cancel reply

You must be logged in to post a comment.

Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us
Privacy
Add us on FacebookMassDevice Network
Follow us on Twitter@MassDevice
Connect with us on LinkedInLinkedIn
Follow us on YouTube YouTube

Copyright © 2019 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS